Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03552289 · ClinicalTrials.gov registry record · NA
Cook Enforcer Post-Market Study
A NA study, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 211
- Enrollment target
NCT03552289 is a NA study that has completed, run by Cook Research Incorporated. The registered enrollment target is 211 participants.
The verdict
NCT03552289, a NA study, has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 211 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the performance of the Cook Advance® Enforcer™ 35 Focal-Force PTA Balloon Catheter (or Enforcer balloon) in treating narrowed blood vessels compared to treatment with a conventional angioplasty balloon.
Interventions
- DEVICE Cook Advance® Enforcer 35 Focal-Force Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter
- DEVICE Conventional angioplasty balloon catheters
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2018-08-07 |
| Est. Completion | 2019-08-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03552289
The ClinicalTrials.gov registry entry for NCT03552289 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cook Advance® Enforcer 35 Focal-Force Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter is the first listed.
NCT03552289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03552289 about?
NCT03552289 is a clinical study titled "Cook Enforcer Post-Market Study". The purpose of this study is to evaluate the performance of the Cook Advance® Enforcer™ 35 Focal-Force PTA Balloon Catheter (or Enforcer balloon) in treating narrowed blood vessels compared to treatment with a conventional angioplasty balloon.
What is the current status of trial NCT03552289?
This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2018-08-07. Estimated completion is 2019-08-27.
What interventions are being tested in trial NCT03552289?
The interventions under investigation include: Cook Advance® Enforcer 35 Focal-Force Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter (DEVICE), Conventional angioplasty balloon catheters (DEVICE).
Who is sponsoring clinical trial NCT03552289?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.